tag:blogger.com,1999:blog-4241416962008169508.post709523947148399741..comments2024-03-27T21:03:58.972-04:00Comments on Just A Life Sciences Blog...: Updated & Added Analysis -- From Lilly's CETP Inhibitor Disappointment -- Amgen/Dezima/Roche/Merck EditionUnknownnoreply@blogger.comBlogger1125tag:blogger.com,1999:blog-4241416962008169508.post-63880158160799450992015-10-23T18:51:12.763-04:002015-10-23T18:51:12.763-04:00The PCSK9 inhibitors are biologics and are priced ...The PCSK9 inhibitors are biologics and are priced as biologics. They also have a very narrow indication. A CETP inhibitor will be far cheaper and will likely have a much broader indication. So, yes, there is room for CETP inhibitors in a PCSK9 inhibitor world. Put another way, CETP inhibitors could be seen as adjuncts or add-ons to statins. PCSK9 inhibitors are unlikely to be seen in the same light.Anonymousnoreply@blogger.com